Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Therapeutic Advances in Neurological Disorders ; 14 (2021). - eISSN 1756-2864
- Keyword
-
COVID-19
mRNA-Impfstoff
Multiple Sklerose
Immunreaktion
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2021
- Creator
-
Petereit, Hela-Felicitas
Tumani, Hayrettin
Zettl, Uwe K.
- DOI
-
10.18725/OPARU-46760
- URN
-
urn:nbn:de:bsz:289-oparu-46836-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Petereit, Hela-Felicitas
- Tumani, Hayrettin
- Zettl, Uwe K.
- Universität Ulm
Time of origin
- 2021
Other Objects (12)
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies